ClinicalTrials.Veeva

Menu

Health Outcomes and Costs (HOC) in Lung Cancer (LC) (HOC-LC)

I

Instituto Nacional de Cancer, Brazil

Status

Unknown

Conditions

Lung Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT02363101
INCA012015

Details and patient eligibility

About

The purpose of this study is to evaluate the costs, health-related quality of life and preference values from lung cancer patients assisted in a Brazilian public health care unit.

Full description

The costs will be assessed by micro-costing approach. All procedures involved in lung cancer at diagnosis, staging, treatment and best supportive care will be assessed.

The health-related quality of life will be assessed by EORTC-QLQ-C30, EQ-5D and EORTC-QLQ-LC13 in all different stages of lung cancer.

An utility measure will be considered. The preference values will be assessed via discrete choice experiment. Two scenarios will be designed and the lung cancer patients will be asked about the preferences.

Enrollment

300 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Clinical diagnosis of lung cancer disease
  • Able to understand the overall concept of study and sign the written informed consent

Exclusion criteria

  • Illiterate
  • Visible cognitive impaired
  • Non-primary lung tumor

Trial contacts and locations

1

Loading...

Central trial contact

Luciene Schluckebier; Alessandra Marins

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems